Clinical Trial

Equity in Modifying Plaque Of WomEn With UndeRtreated Calcified Coronary Artery Disease

Study acronym: EMPOWER CAD
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Post-market, prospective, multi-center, single-arm observational study to generate real-world clinical evidence associated with coronary IVL in a population of female subjects with calcified coronary artery disease.
Protocol Amendment History 38 amendments
This ClinicalTrials.gov record has been amended 38 times since 2023-03-02; most recent amendment 2026-05-05.
Status change: Recruiting → Active, Not Recruiting 2024-10-28
Status change: Not Yet Recruiting → Recruiting 2023-05-04
Trial Details
NCT Number NCT05755711
Lead Sponsor Shockwave Medical, Inc.
Conditions Coronary Artery Disease
Enrollment 399 participants
Start Date 2023-05-03
Primary Completion 2024-12-11 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-07-30